PubRank

Gust H Bardy

Author PubWeight™ 57.38‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008 5.13
2 Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med 2008 4.33
3 Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy. Circulation 2008 3.54
4 Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation 2006 2.60
5 Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. Circulation 2009 2.57
6 Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population. Circulation 2009 2.34
7 Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol 2013 2.28
8 Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. Heart Rhythm 2013 2.22
9 A critic's assessment of our approach to cardiac arrest. N Engl J Med 2011 2.04
10 No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol 2008 2.03
11 Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation 2007 1.87
12 Dynamic pressure--flow velocity relationships in the human cerebral circulation. Stroke 2003 1.83
13 No benefit of a dual coil over a single coil ICD lead: evidence from the Sudden Cardiac Death in Heart Failure Trial. Heart Rhythm 2013 1.83
14 Tripling survival from sudden cardiac arrest via early defibrillation without traditional education in cardiopulmonary resuscitation. Circulation 2002 1.67
15 An ECG index of myocardial scar enhances prediction of defibrillator shocks: an analysis of the Sudden Cardiac Death in Heart Failure Trial. Heart Rhythm 2010 1.65
16 Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial. J Am Coll Cardiol 2002 1.64
17 Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Heart Rhythm 2010 1.54
18 Thyroid function in heart failure and impact on mortality. JACC Heart Fail 2013 1.47
19 Feasibility of defibrillation and automatic arrhythmia detection using an exclusively subcutaneous defibrillator system in canines. J Cardiovasc Electrophysiol 2012 1.39
20 Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials. JAMA 2013 1.25
21 Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy. Am Heart J 2012 1.17
22 Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study. J Am Coll Cardiol 2008 1.03
23 Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004. Am Heart J 2005 1.01
24 Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial. J Cardiovasc Electrophysiol 2008 1.00
25 Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis. Europace 2010 0.99
26 Subcutaneous chronic implantable defibrillation systems in humans. J Interv Card Electrophysiol 2012 0.98
27 Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J 2007 0.98
28 Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J 2007 0.97
29 Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J 2008 0.92
30 Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J 2007 0.87
31 Absence of bilateral vision loss from amiodarone: a randomized trial. Am Heart J 2007 0.79
32 Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure. Am Heart J 2006 0.79
33 Implantable cardioverter defibrillator therapy in patients with prior coronary revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). J Cardiovasc Electrophysiol 2008 0.78
34 Quality of life effects of automatic external defibrillators in the home: results from the Home Automatic External Defibrillator Trial (HAT). Am Heart J 2010 0.77
35 The end is near....of tinkering that is. Heart Rhythm 2010 0.75
36 Reply: rapid rate nonsustained ventricular tachycardia found on ICD interrogation: relationship of RR-NSVT to outcomes in the SCD-HeFT trial. J Am Coll Cardiol 2013 0.75
37 Reply: circadian variations of ventricular arrhythmias and sleep-disordered breathing in HF patients. J Am Coll Cardiol 2014 0.75
38 Key clinical insights from the sudden cardiac death in heart failure trial. J Cardiovasc Nurs 2007 0.75
39 Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias. Am J Crit Care 2008 0.75
40 Effect of left ventricular ejection fraction and QRS duration on the survival benefit of implantable cardioverter-defibrillators: meta-analysis of primary prevention trials. Heart Rhythm 2012 0.75